CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4/A Planned sale Chief Financial Officer sold 10,000 shares at an average $17.04 ($170,387)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $17.04 ($170,387)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer sold 1,258 shares at $15.01 ($18,880)
- 4 Planned sale Director sold 1,406 shares at $15.00 ($21,090)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer sold 275 shares at $12.31 ($3,385)
- 4 Planned sale Director sold 2,811 shares at $14.00 ($39,354)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Product Officer sold 4,378 shares at $12.61 ($55,194)
- 4 Open-market sale Chief Commercial Officer sold 5,329 shares at $12.61 ($67,183)
Page 3 of 15 · 290 filings